These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23645770)

  • 1. Surgical resection of brain metastases from breast cancer in the modern era: clinical outcome and prognostic factors.
    Tabouret E; Metellus P; Tallet-Richard A; Figarella-Branger D; Charaffe-Jauffret E; Viens P; Gonçalves A
    Anticancer Res; 2013 May; 33(5):2159-67. PubMed ID: 23645770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
    Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
    BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.
    Braccini AL; Azria D; Thezenas S; Romieu G; Ferrero JM; Jacot W
    Breast; 2013 Oct; 22(5):993-8. PubMed ID: 23831232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
    Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
    Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer brain metastases - A 12 year review of treatment outcomes.
    De Ieso PB; Schick U; Rosenfelder N; Mohammed K; Ross GM
    Breast; 2015 Aug; 24(4):426-33. PubMed ID: 25881974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival in patients with brain metastases from breast cancer: the importance of HER-2 status.
    Eichler AF; Kuter I; Ryan P; Schapira L; Younger J; Henson JW
    Cancer; 2008 Jun; 112(11):2359-67. PubMed ID: 18361426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
    Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
    Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer.
    Zegarac M; Nikolic S; Gavrilovic D; Jevric M; Kolarevic D; Nikolic-Tomasevic Z; Kocic M; Djurisic I; Inic Z; Ilic V; Santrac N
    J BUON; 2013; 18(4):859-65. PubMed ID: 24344009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
    Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
    Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
    Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients with brain metastases receiving trastuzumab treatment for metastatic breast cancer.
    Witzel I; Kantelhardt EJ; Milde-Langosch K; Ihnen M; Zeitz J; Harbeck N; Jänicke F; Müller V
    Onkologie; 2011; 34(6):304-8. PubMed ID: 21625183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy.
    Leone JP; Lee AV; Brufsky AM
    Cancer Med; 2015 Jul; 4(7):989-94. PubMed ID: 25756607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer.
    Meimarakis G; Rüttinger D; Stemmler J; Crispin A; Weidenhagen R; Angele M; Fertmann J; Hatz RA; Winter H
    Ann Thorac Surg; 2013 Apr; 95(4):1170-80. PubMed ID: 23391172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology).
    Kaplan MA; Isikdogan A; Koca D; Kucukoner M; Gumusay O; Yildiz R; Dayan A; Demir L; Geredeli C; Kocer M; Arslan UY; Inal A; Unal OU; Mert AG; Bilici M; Ozkan M; Elkiran ET; Yaman S; Durnalı AG; Suner A; Alici S; Tarhan MO; Boruban C; Urakci Z; Buyukberber S
    Oncology; 2012; 83(3):141-50. PubMed ID: 22814315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.